[{"address1": "225 Franklin Street", "address2": "26th Floor", "city": "Boston", "state": "MA", "zip": "02110", "country": "United States", "phone": "857 246 8998", "website": "https://www.pieris.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Pieris Pharmaceuticals, Inc., a biotechnology company, discovers and develops biotechnological applications. The company focuses on the development of its 4-1BB bispecifics immuno-oncology (IO) programs. Its clinical pipeline consists of IO bispecifics, including S095012 (PRS-344), a bispecific Mabcalin compound targeting PD-L1 and 4-1BB in partnership with Les Laboratoires Servier and Institut de Recherches Internationales Servier; SGN-BB228 (PRS-346), a CD228 x 4-1BB bispecific antibody-Anticalin compound targeting CD228 and 4-1BB in partnership with Pfizer Inc.; and BOS-342 (PRS-342), a GPC3 x 4-1BB bispecific Mabcalin compound targeting GPC3 and 4-1BB in partnership with Boston Pharmaceuticals, which are in phase 1 studies. The company was founded in 2001 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 46, "companyOfficers": [{"maxAge": 1, "name": "Mr. Stephen S. Yoder J.D.", "age": 47, "title": "CEO, President & Director", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 744134, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas  Bures", "age": 48, "title": "Senior VP, CFO & Treasurer", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 487501, "exercisedValue": 0, "unexercisedValue": 5120349}, {"maxAge": 1, "name": "Dr. Shane  Olwill Ph.D.", "age": 47, "title": "Senior VP & Chief Development Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 463909, "exercisedValue": 0, "unexercisedValue": 8086283}, {"maxAge": 1, "name": "Maria  Kelman", "title": "Executive Director of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Prompong  Chaikul", "age": 36, "title": "Chief Supply Chain Officer", "yearBorn": 1987, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 16.01, "open": 16.07, "dayLow": 16.07, "dayHigh": 16.17, "regularMarketPreviousClose": 16.01, "regularMarketOpen": 16.07, "regularMarketDayLow": 16.07, "regularMarketDayHigh": 16.17, "beta": 0.669, "forwardPE": -80.85, "volume": 4182, "regularMarketVolume": 4182, "averageVolume": 130876, "averageVolume10days": 8120, "averageDailyVolume10Day": 8120, "marketCap": 21348280, "fiftyTwoWeekLow": 6.2, "fiftyTwoWeekHigh": 24.8, "priceToSalesTrailing12Months": 1.022819, "fiftyDayAverage": 16.87372, "twoHundredDayAverage": 13.401165, "currency": "USD", "enterpriseValue": 1617280, "profitMargins": -1.14115, "floatShares": 808119, "sharesOutstanding": 1320240, "sharesShort": 36442, "sharesShortPriorMonth": 49417, "sharesShortPreviousMonthDate": 1723680000, "dateShortInterest": 1726185600, "sharesPercentSharesOut": 0.0276, "heldPercentInsiders": 0.00066, "heldPercentInstitutions": 0.47714, "shortRatio": 1.12, "shortPercentOfFloat": 0.0343, "bookValue": 14.168, "priceToBook": 1.1413044, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -23818000, "trailingEps": -19.21, "forwardEps": -0.2, "lastSplitFactor": "2:1", "lastSplitDate": 1417996800, "enterpriseToRevenue": 0.077, "enterpriseToEbitda": -0.143, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "PIRS", "underlyingSymbol": "PIRS", "shortName": "Pieris Pharmaceuticals, Inc.", "longName": "Pieris Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1420209000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "8fe43177-b19a-3ae9-9f2a-563a55a71915", "gmtOffSetMilliseconds": -14400000, "currentPrice": 16.17, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 19731000, "totalCashPerShare": 14.945, "ebitda": -11335000, "quickRatio": 3.845, "currentRatio": 3.948, "totalRevenue": 20872000, "revenuePerShare": 16.66, "returnOnAssets": -0.13184, "returnOnEquity": -0.80461997, "freeCashflow": -25493500, "operatingCashflow": -37868000, "grossMargins": 0.23256001, "ebitdaMargins": -0.54307, "operatingMargins": -0.56899, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-10"}]